Wang Shao-jie, Bai Wen, Wang Chun-ling
Department of TCM, People's Hospital of Peking University, Beijing.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Apr;27(4):347-51.
To study the preventive and therapeutic effect of Huaxian Decoction (HXD) on bleomycin-induced pulmonary fibrosis in mice by taking treatment of ligustrazin and prednisone as controls, for investigate the clinical value and possible mechanism in treatment of pulmonary fibrosis by traditional Chinese herbs.
A total of 96 male ICR mice, aged 6 to 8 weeks, were randomly divided into 8 groups. Pulmonary fibrosis was induced in the model group by intranasal instillation of bleomycin 5 mg/kg. HXD were given via gastrogavage to the HXD prevention group and treatment group respectively at 48 h before and 14 days after they were modeled with the same method, and the groups of ligustrazin and prednisone, treatment and prevention, were managed the same as for HXD groups, but with ligustazin and prednisone instead of HXD respectively. Bronchoalveolar lavage fluid (BALF) and lung tissue of animals were gathered on day 28. Cellular ultrastructural changes of lung was examined under electron microscope by HE, Masson stain; Content of hydroxyproline (HYP) in lung tissue was assessed by acidolysis method; and concentration of transforming growth factor-beta1 (TGF-beta1) in BALF was assessed by ELISA.
Pulmonary coefficient was significantly lower in all the drug intervening groups than that in the model group (P < 0.05), improvement on alveolitis and pulmonary fibrosis were alsonaged the safter intervention, especially in the HXD prevention group (Pinstead < 0.05). HYP content in lung tissue and TGF-beta1 content in BALF lowered at the same time.
Early stage application of HXD can alleviate bleomycin-induced alveolitis and pulmonary fibrosis in mice to certain degree, suggesting that Chinese herbs with supplementing qi and activating blood circulation effect could play a definite preventive action on pulmonary fibrosis, and the inhibition on expressions of TGF-beta1 in lung tissues may be one of the mechanisms.
以川芎嗪和泼尼松治疗为对照,研究化纤汤(HXD)对博莱霉素诱导的小鼠肺纤维化的防治作用,探讨中药治疗肺纤维化的临床价值及可能机制。
将96只6至8周龄的雄性ICR小鼠随机分为8组。模型组通过鼻内滴注5mg/kg博莱霉素诱导肺纤维化。HXD预防组和治疗组分别在造模前48小时和造模后14天通过灌胃给予HXD,川芎嗪和泼尼松组的治疗和预防组与HXD组处理相同,但分别用川芎嗪和泼尼松代替HXD。在第28天收集动物的支气管肺泡灌洗液(BALF)和肺组织。通过HE、Masson染色在电子显微镜下检查肺的细胞超微结构变化;采用酸解法评估肺组织中羟脯氨酸(HYP)的含量;采用ELISA法评估BALF中转化生长因子-β1(TGF-β1)的浓度。
所有药物干预组的肺系数均显著低于模型组(P<0.05),干预后肺泡炎和肺纤维化也有改善,尤其是HXD预防组(P<0.05)。肺组织中HYP含量和BALF中TGF-β1含量同时降低。
早期应用HXD可在一定程度上减轻博莱霉素诱导的小鼠肺泡炎和肺纤维化,提示具有益气活血作用的中药对肺纤维化可能有一定的预防作用,抑制肺组织中TGF-β1的表达可能是其机制之一。